{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T15:37:19Z","timestamp":1764603439951},"reference-count":53,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sexual Medicine Reviews"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.sxmr.2017.02.002","type":"journal-article","created":{"date-parts":[[2017,3,21]],"date-time":"2017-03-21T16:08:54Z","timestamp":1490112534000},"page":"256-265","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["The Graham Jackson Memorial Lecture ISSM 2016\u2014\u201cThe Man Who Knew Too Much\u201d: Time to Recognize Erectile Dysfunction and Low Testosterone as Independent Risk Factors for Cardiovascular Disease"],"prefix":"10.1093","volume":"5","author":[{"given":"Geoffrey","family":"Hackett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"10.1016\/j.sxmr.2017.02.002_bib1","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.mayocp.2012.06.015","article-title":"The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease","volume":"87","author":"Nehra","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.sxmr.2017.02.002_bib2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.7326\/0003-4819-55-1-33","article-title":"Factors of risk in the development of coronary heart disease: 6-year follow-up experience. The Framingham Study","volume":"55","author":"Kannel","year":"1961","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.sxmr.2017.02.002_bib3","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4065\/84.2.108","article-title":"A\u00a0population-based, longitudinal study of erectile dysfunction and future coronary artery disease","volume":"84","author":"Inman","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.sxmr.2017.02.002_bib4","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.sxmr.2017.02.002_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/CIRCOUTCOMES.112.966903","article-title":"Prediction of cardiovascular events and all-cause mortality with erectile dysfunction: a systematic review and meta-analysis of cohort studies","volume":"6","author":"Vlachopoulos","year":"2013","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.sxmr.2017.02.002_bib6","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jacc.2009.08.058","article-title":"Does erectile dysfunction contribute to cardiovascular disease risk prediction beyond the Framingham Risk Score?","volume":"55","author":"Araujo","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.sxmr.2017.02.002_bib7","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1136\/bmj.39609.449676.25","article-title":"Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2","volume":"336","author":"Hippisley-Cox","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.sxmr.2017.02.002_bib8","unstructured":"Joint British Societies Risk Calculator 3. Available at: http:\/\/www.jbs3risk.com\/. Accessed December 12,\u00a02016."},{"key":"10.1016\/j.sxmr.2017.02.002_bib9","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1136\/bmj.39560.442095.AD","article-title":"Management of type 2 diabetes: summary of updated NICE guidance","volume":"336","author":"Home","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.sxmr.2017.02.002_bib10","unstructured":"Tucker N, Becker S. The keep it simple guide to QOF 2015\/2016 England. Available at: http:\/\/www.nbmedical.com\/pdf\/Keep%20it%20Simple%20QOF%202015.pdf. Accessed December 12,\u00a02016."},{"key":"10.1016\/j.sxmr.2017.02.002_bib11","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/ijcp.12200","article-title":"The assessment of vascular risk in men with erectile dys-function: the role of the cardiologist and general physician","volume":"67","author":"Jackson","year":"2013","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.sxmr.2017.02.002_bib12","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.jacc.2007.10.069","article-title":"Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors","volume":"51","author":"Gazzaruso","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.sxmr.2017.02.002_bib13","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1093\/eurheartj\/ehl142","article-title":"Association between erectile dysfunction and coronary artery disease. Role of coronary clinical presentation and extent of coronary vessels involvement: the COBRA trial","volume":"27","author":"Montorsi","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.sxmr.2017.02.002_bib14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ahj.2012.04.006","article-title":"Prognostic utility of erectile dysfunction for cardiovascular disease in younger men and those with diabetes","volume":"164","author":"Miner","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.sxmr.2017.02.002_bib15","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.1210\/jc.2013-3272","article-title":"In older men an optimal plasma testosterone is associated with reduced all-cause mortality and higher dihydrotestosterone with reduced ischemic heart disease mortality, while estradiol levels do not predict mortality","volume":"99","author":"Yeap","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.sxmr.2017.02.002_bib16","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1210\/jc.2013-2052","article-title":"Late-onset hypogonadism and mortality in aging men","volume":"99","author":"Pye","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.sxmr.2017.02.002_bib17","doi-asserted-by":"crossref","first-page":"e1001372","DOI":"10.1371\/journal.pmed.1001372","article-title":"Erectile dysfunction severity as a risk marker for cardiovascular disease hospitalisation and all-cause mortality\u2014a prospective study","volume":"10","author":"Banks","year":"2013","journal-title":"PLoS Med"},{"key":"10.1016\/j.sxmr.2017.02.002_bib18","first-page":"2338","article-title":"Dietary factors, Mediterranean diet and erectile dysfunction","volume":"7","author":"Esposito","year":"2010","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2017.02.002_bib19","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1001\/archinternmed.2011.440","article-title":"The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: a systematic review and meta-analysis","volume":"171","author":"Gupta","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.sxmr.2017.02.002_bib20","first-page":"156","article-title":"Effects of weight loss intervention on erectile function in older men with type 2 diabetes in the Look AHEAD trial","volume":"7","author":"Wing","year":"2010","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2017.02.002_bib21","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1136\/bmj.315.7123.1641","article-title":"Sex and death: are they related? Findings from the Caerphilly cohort study","volume":"315","author":"Smith","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.sxmr.2017.02.002_bib22","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.amjcard.2009.08.671","article-title":"Sexual activity, erectile dysfunction and incident cardiovascular events","volume":"105","author":"Hall","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.sxmr.2017.02.002_bib23","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/j.2047-2927.2013.00139.x","article-title":"Frequency of sexual activity and cardiovascular risk in subjects with erectile dysfunction: cross-sectional and longitudinal analyses","volume":"1","author":"Corona","year":"2013","journal-title":"Andrology"},{"key":"10.1016\/j.sxmr.2017.02.002_bib24","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1136\/heartjnl-2015-309223","article-title":"Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all-cause mortality","volume":"102","author":"Anderson","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.sxmr.2017.02.002_bib25","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/ijcp.12779","article-title":"Serum testosterone, testosterone replacement therapy and all- cause mortality in men with type 2 diabetes: retrospective consideration of the impact of PDE5 inhibitors and statins","volume":"70","author":"Hackett","year":"2016","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.sxmr.2017.02.002_bib26","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.eururo.2004.10.002","article-title":"Chronic treatment with tadalafil improves endothelial function in men with increased cardiovascular risk","volume":"47","author":"Rosano","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.sxmr.2017.02.002_bib27","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/CIRCHEARTFAILURE.110.944694","article-title":"PDE5 inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry, and clinical status in patients with stable systolic heart failure results of a 1-year, prospective, randomized, placebo-controlled study","volume":"4","author":"Guazzi","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.sxmr.2017.02.002_bib28","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1007\/s11255-015-1071-4","article-title":"Phosphodiesterase type 5 inhibitors and kidney disease","volume":"47","author":"Afsar","year":"2015","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.sxmr.2017.02.002_bib29","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.sxmr.2015.10.004","article-title":"The role of PDE5 inhibitors and the NO\/cGMP pathway in cancer","volume":"4","author":"Peak","year":"2016","journal-title":"Sex Med Rev"},{"key":"10.1016\/j.sxmr.2017.02.002_bib30","doi-asserted-by":"crossref","first-page":"461","DOI":"10.4103\/1008-682X.123678","article-title":"The role of statins in erectile dysfunction: a systematic review and meta-analysis","volume":"16","author":"Cui","year":"2014","journal-title":"Asian J Androl"},{"key":"10.1016\/j.sxmr.2017.02.002_bib31","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1161\/CIRCULATIONAHA.107.719005","article-title":"Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European Prospective Investigation Into Cancer in Norfolk (EPIC-Norfolk) prospective population study","volume":"116","author":"Khaw","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.sxmr.2017.02.002_bib32","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1530\/EJE-09-0284","article-title":"Endogenous sex hormones and the prospective association with cardiovascular disease and mortality in men: the Troms\u00f8 study","volume":"161","author":"Vikan","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.sxmr.2017.02.002_bib33","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/hrt.2010.210757","article-title":"Endogenous testosterone and cardiovascular disease in healthy men: a meta-analysis","volume":"97","author":"Ruige","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.sxmr.2017.02.002_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12902-015-0034-1","article-title":"Low concentrations of serum testosterone predicts acute myocardial infarction in men with type 2 diabetes mellitus","volume":"15","author":"Daka","year":"2015","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.sxmr.2017.02.002_bib35","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1210\/jc.2011-1137","article-title":"Endogenous testosterone and mortality in men: a systematic review and meta-analysis","volume":"96","author":"Araujo","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.sxmr.2017.02.002_bib36","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1093\/eurheartj\/ehq009","article-title":"Low serum testosterone levels are associated with increased risk of mortality in a population-based cohort of men aged 20\u201379","volume":"31","author":"Haring","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.sxmr.2017.02.002_bib37","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2337\/diacare.25.1.55","article-title":"Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study","volume":"25","author":"Oh","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.sxmr.2017.02.002_bib38","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/oxfordjournals.aje.a008832","article-title":"Low levels of sex hormone-binding globulin and testosterone predict the development of non\u2013insulin-dependent diabetes mellitus in men. MRFIT Research Group. Multiple Risk Factor Intervention Trial","volume":"143","author":"Haffner","year":"1996","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.sxmr.2017.02.002_bib39","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1210\/jc.2016-1778","article-title":"Low testosterone: a risk marker rather than a risk factor for type 2 diabetes","volume":"101","author":"Holmboe","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.sxmr.2017.02.002_bib40","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1210\/jc.2011-2513","article-title":"Characteristics of androgen deficiency in late-onset hypogonadism: results from the European Male Aging Study (EMAS)","volume":"97","author":"Tajar","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.sxmr.2017.02.002_bib41","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.beem.2013.05.002","article-title":"Diagnosis and treatment of\u00a0late onset hypogonadism: systematic review and meta-analysis of TRT outcomes","volume":"27","author":"Corona","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.sxmr.2017.02.002_bib42","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1001\/jama.2013.280386","article-title":"Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels","volume":"310","author":"Vigen","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.sxmr.2017.02.002_bib43","doi-asserted-by":"crossref","first-page":"e85805","DOI":"10.1371\/journal.pone.0085805","article-title":"Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men","volume":"9","author":"Finkle","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.sxmr.2017.02.002_bib44","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1530\/EJE-13-0321","article-title":"Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes","volume":"169","author":"Muraleedaran","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.sxmr.2017.02.002_bib45","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1210\/jc.2011-2591","article-title":"Testosterone treatment and mortality in men with low testosterone","volume":"97","author":"Shores","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.sxmr.2017.02.002_bib46","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.amjcard.2015.11.063","article-title":"Impact of testosterone replacement therapy on myocardial infarction, stroke, and death in men with low testosterone concentrations in an integrated health care system","volume":"117","author":"Anderson","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.sxmr.2017.02.002_bib47","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1093\/eurheartj\/ehv346","article-title":"Normalization of testosterone level is associated with reduced incidence of myocardial infarction and mortality in men","volume":"36","author":"Sharma","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.sxmr.2017.02.002_bib48","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S2213-8587(16)00112-1","article-title":"Survival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort study","volume":"4","author":"Wallis","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.sxmr.2017.02.002_bib49","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12916-016-0700-9","article-title":"Effects of testosterone treatment on body fat and lean mass in obese men on a hypocaloric diet: a randomised controlled trial","volume":"14","author":"Ng Tang Fui","year":"2016","journal-title":"BMC Med"},{"key":"10.1016\/j.sxmr.2017.02.002_bib50","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000452499","article-title":"Testosterone deficiency and testosterone treatment in older men","volume":"63","author":"Saad","year":"2017","journal-title":"Gerontology"},{"key":"10.1016\/j.sxmr.2017.02.002_bib51","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jacc.2015.12.005","article-title":"Testosterone and cardiovascular disease","volume":"67","author":"Kloner","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.sxmr.2017.02.002_bib52","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/ijcp.12275","article-title":"Erectile dysfunction and asymptomatic coronary artery disease: frequently detected by computed tomography coronary angiography but not by exercise electrocardiography","volume":"67","author":"Jackson","year":"2013","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.sxmr.2017.02.002_bib53","first-page":"1841","article-title":"British Society for Sexual Medicine guidelines on the management of erectile dysfunction","volume":"5","author":"Hackett","year":"2008","journal-title":"J\u00a0Sex Med"}],"container-title":["Sexual Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2050052117300112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2050052117300112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T19:36:42Z","timestamp":1672774602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2050052117300112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S2050052117300112"],"URL":"https:\/\/doi.org\/10.1016\/j.sxmr.2017.02.002","relation":{},"ISSN":["2050-0521"],"issn-type":[{"value":"2050-0521","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Graham Jackson Memorial Lecture ISSM 2016\u2014\u201cThe Man Who Knew Too Much\u201d: Time to Recognize Erectile Dysfunction and Low Testosterone as Independent Risk Factors for Cardiovascular Disease","name":"articletitle","label":"Article Title"},{"value":"Sexual Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sxmr.2017.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2017, Published by Elsevier Inc. on behalf of the International Society for Sexual Medicine.","name":"copyright","label":"Copyright"}]}}